Works matching IS 20479158 AND DT 2023 AND VI 12 AND IP 1
Results: 59
Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00392-8
- By:
- Publication type:
- Article
Supplementation with high-GABA-producing Lactobacillus plantarum L5 ameliorates essential tremor triggered by decreased gut bacteria-derived GABA.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00391-9
- By:
- Publication type:
- Article
Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00389-3
- By:
- Publication type:
- Article
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00383-9
- By:
- Publication type:
- Article
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00338-0
- By:
- Publication type:
- Article
Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00390-w
- By:
- Publication type:
- Article
N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00386-6
- By:
- Publication type:
- Article
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00387-5
- By:
- Publication type:
- Article
Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00385-7
- By:
- Publication type:
- Article
Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00376-8
- By:
- Publication type:
- Article
Intranasal administration of induced pluripotent stem cell-derived cortical neural stem cell-secretome as a treatment option for Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00384-8
- By:
- Publication type:
- Article
Role of dopamine in the pathophysiology of Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00378-6
- By:
- Publication type:
- Article
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00382-w
- By:
- Publication type:
- Article
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00380-y
- By:
- Publication type:
- Article
A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00379-5
- By:
- Publication type:
- Article
Research progress on the role of extracellular vesicles in neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00375-9
- By:
- Publication type:
- Article
NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00381-x
- By:
- Publication type:
- Article
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00374-w
- By:
- Publication type:
- Article
Early GCase activity is a predictor of long-term cognitive decline in Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00373-x
- By:
- Publication type:
- Article
α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00372-y
- By:
- Publication type:
- Article
The potential impact of clinical factors on blood-based biomarkers for Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00371-z
- By:
- Publication type:
- Article
Multidimensional biomarkers for multiple system atrophy: an update and future directions.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00370-0
- By:
- Publication type:
- Article
Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00369-7
- By:
- Publication type:
- Article
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00368-8
- By:
- Publication type:
- Article
Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00367-9
- By:
- Publication type:
- Article
Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00365-x
- By:
- Publication type:
- Article
Brain metabolism in Alzheimer's disease: biological mechanisms of exercise.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00364-y
- By:
- Publication type:
- Article
Update on the pathological roles of prostaglandin E<sub>2</sub> in neurodegeneration in amyotrophic lateral sclerosis.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00366-w
- By:
- Publication type:
- Article
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00363-z
- By:
- Publication type:
- Article
Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00362-0
- By:
- Publication type:
- Article
Cognitive dysfunction of patients infected with SARS-CoV-2 omicron variant in Shanghai, China.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
An open-label multiyear study of sargramostim-treated Parkinson's disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00361-1
- By:
- Publication type:
- Article
Longitudinal evolution of cortical thickness signature reflecting Lewy body dementia in isolated REM sleep behavior disorder: a prospective cohort study.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00356-y
- By:
- Publication type:
- Article
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00355-z
- By:
- Publication type:
- Article
Correction: Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson's disease patients.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Microtubule acetylation dyshomeostasis in Parkinson's disease.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00354-0
- By:
- Publication type:
- Article
An AARS1 variant identified to cause adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00350-4
- By:
- Publication type:
- Article
Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson's disease patients.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00348-y
- By:
- Publication type:
- Article
Argyrophilic grain disease is common in older adults and may be a risk factor for suicide: a study of Japanese forensic autopsy cases.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00352-2
- By:
- Publication type:
- Article
Modulating arousal to overcome gait impairments in Parkinson's disease: how the noradrenergic system may act as a double-edged sword.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00347-z
- By:
- Publication type:
- Article
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00346-0
- By:
- Publication type:
- Article
Seed amplification assay of nasal swab extracts for accurate and non-invasive molecular diagnosis of neurodegenerative diseases.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00345-1
- By:
- Publication type:
- Article
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00342-4
- By:
- Publication type:
- Article
Alleviating the unwanted effects of oxidative stress on Aβ clearance: a review of related concepts and strategies for the development of computational modelling.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00344-2
- By:
- Publication type:
- Article
Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00343-3
- By:
- Publication type:
- Article
Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.
- Published in:
- Translational Neurodegeneration, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40035-023-00341-5
- By:
- Publication type:
- Article